Published in Medical Letter on the CDC and FDA, October 14th, 2001
Pentagon officials declined to say how many doses of the vaccine they have left following cutbacks ordered last year to conserve supplies. "I'm not going to talk about it," said Pentagon spokesman Jim Turner.
But with the sole manufacturer awaiting federal license approval, the supply problem has remained unresolved for well over a year. The Pentagon originally wanted to immunize all 2.4 million members of the active and reserve military against anthrax, which is a naturally occurring...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.